Skip navigation

Advanced Methods for Lay Summary Implementation and Improving Communication with Patients

September 24-25, 2019
  • Philadelphia, PA

With new guidelines addressing the complex nature of returning individual results to patients and growing pressure to remain non-promotional, there is no better time to join your colleagues from across the bio/pharma industry than at CBI’s 4th Annual Lay Summaries Summit! Benchmark with your peers to celebrate progress made, combat challenges yet to overcome and plan for the future.

Key Attendee Benefits:

  • Assess how to improve your internal lay summary implementation while listening to various case studies
  • Evaluate the current timelines projected for the EU Portal to go live and review EU Member State readiness
  • Explore patient engagement beyond lay summaries
  • Learn how to overcome unique and universal challenges faced by small and big pharmaceutical companies
  • Hear guidelines for returning individual results to participants
  • Navigate lessons learned from implementing a communication plan for clinical trial participants

See you there!

Previous Attendee Acclaim:

Excellent conference — expert insight from leaders
in patient communications.

Chief Operating Officer, Oxford PharmaGenesis

It was a well-organized and informative conference.

Director, Clinical Trial Information Disclosure, Daiichi Sankyo, Inc.

I'm always impressed with sponsors' willingness to share best practices in the development of their lay summaries processes; it provides such great learnings for those in attendance at varying stages of their implementation.

Senior Director, Patient Engagement, CISCRP

Useful and intentional space to discuss common goal of effective plain language communication and stay abreast
of industry standards/regulatory guidance.

Anonymous

I found the interactive sessions most engaging and informative, allowing the participants to gauge the level of preparedness across industry and to zoom in in common problems.

Associate Director, Regulatory Medical Writing, Johnson and Johnson

I find this conference invaluable and hope that we continue to hold it each year. It is amazing how willing everyone is to share lessons learned and what they are working on to improve
their plain language summary program as well as
expand their patient communications.

Operational Excellence Expert, Novartis Pharmaceuticals

4th Annual Lay Summaries Summit

Advanced Methods for Lay Summary Implementation and Improving Communication with Patients

With new guidelines addressing the complex nature of returning individual results to patients and growing pressure to remain non-promotional, there is no better time to join your colleagues from across the bio/pharma industry than at CBI’s 4th Annual Lay Summaries Summit! Benchmark with your peers to celebrate progress made, combat challenges yet to overcome and plan for the future.

Key Attendee Benefits:

  • Assess how to improve your internal lay summary implementation while listening to various case studies
  • Evaluate the current timelines projected for the EU Portal to go live and review EU Member State readiness
  • Explore patient engagement beyond lay summaries
  • Learn how to overcome unique and universal challenges faced by small and big pharmaceutical companies
  • Hear guidelines for returning individual results to participants
  • Navigate lessons learned from implementing a communication plan for clinical trial participants

See you there!

Previous Attendee Acclaim:

Excellent conference — expert insight from leaders
in patient communications.

Chief Operating Officer, Oxford PharmaGenesis

It was a well-organized and informative conference.

Director, Clinical Trial Information Disclosure, Daiichi Sankyo, Inc.

I'm always impressed with sponsors' willingness to share best practices in the development of their lay summaries processes; it provides such great learnings for those in attendance at varying stages of their implementation.

Senior Director, Patient Engagement, CISCRP

Useful and intentional space to discuss common goal of effective plain language communication and stay abreast
of industry standards/regulatory guidance.

Anonymous

I found the interactive sessions most engaging and informative, allowing the participants to gauge the level of preparedness across industry and to zoom in in common problems.

Associate Director, Regulatory Medical Writing, Johnson and Johnson

I find this conference invaluable and hope that we continue to hold it each year. It is amazing how willing everyone is to share lessons learned and what they are working on to improve
their plain language summary program as well as
expand their patient communications.

Operational Excellence Expert, Novartis Pharmaceuticals